Portal:CPTAC

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
Line 9: Line 9:
}}
}}
-
<div style="float:left; width:72%"> <!-- This width add to the the margin below to equal 99%-->
+
<div style="float:left; width:68%"> <!-- This width add to the the margin below to equal 99%-->
 +
 
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal
|<!-- TITLE OF BOX -->
|<!-- TITLE OF BOX -->
Line 22: Line 23:
</div>
</div>
-
<div style="float:right; width:27%"> <!-- This margin should be right of the above -->
+
<div style="float:right; width:31%"> <!-- This margin should be right of the above -->
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal

Revision as of 18:04, 3 October 2017

edit  

CPTAC Pathways

Welcome to the CPTAC Pathway Portal

This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).

The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.

The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011.

edit  

Cancer Hallmark Categories

Sustaining proliferative signaling

Hepatocyte growth factor receptor signaling (Homo sapiens)

Image does not exist
Hepatocyte growth factor receptor signaling
Evading growth suppressors

TGF-beta receptor signaling (Homo sapiens)

Image does not exist
TGF-beta receptor signaling
Activating invasion and metastasis

Focal adhesion: PI3K-Akt-mTOR-signaling (Homo sapiens)

Image does not exist
Focal adhesion: PI3K-Akt-mTOR-signaling
Enabling replicative immortality

ncRNAs involved in STAT3 signaling in hepatocellular carcinoma (Homo sapiens)

Image does not exist
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma
Inducing angiogenesis

Angiogenesis (Homo sapiens)

Image does not exist
Angiogenesis
Resisting cell death

miRNA regulation of p53 pathway in prostate cancer (Homo sapiens)

Image does not exist
miRNA regulation of p53 pathway in prostate cancer
Deregulating cellular energetics

Metabolic reprogramming in colon cancer (Homo sapiens)

Image does not exist
Metabolic reprogramming in colon cancer
Genome instability and mutation

Base excision repair (Homo sapiens)

Image does not exist
Base excision repair
Tumor promoting inflammation

IL1 signaling (Homo sapiens)

Image does not exist
IL1 signaling
Avoiding immune destruction

Altered glycosylation of MUC1 in tumor microenvironment (Homo sapiens)

Image does not exist
Altered glycosylation of MUC1 in tumor microenvironment
Therapeutics

MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement (Homo sapiens)

Image does not exist
MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement

edit  

Featured Pathways

edit  

Pathway Curation

On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.

Getting Started

Resources

Curation projects

edit  

Useful Links